Latest 10-Q quarterly reports

NASDAQ
Universal Electronics Inc. reported a 14.4% decrease in net sales for the first quarter of 2026, alongside a reduction in gross margin, driven by unfavorable sales mix and tariff costs.
NASDAQ
Metagenomi Therapeutics, Inc. reported a net loss of $23.1 million for the first quarter of 2026, with a decrease in collaboration revenue and operating expenses.
NASDAQ
Pliant Therapeutics reported a net loss of $20.0 million for the first quarter of 2026, a significant decrease from the prior year's loss of $56.2 million, driven by reduced R&D expenses.
NASDAQ
Sana Biotechnology, Inc. filed its Form 10-Q for the quarter ended March 31, 2026, detailing a net loss of $47.2 million and highlighting progress in its cell engineering platforms while acknowledging substantial doubt about its ability to continue as a going concern.
NASDAQ
Life360, Inc. announced a 38% increase in total revenue for the first quarter of 2026, driven by significant growth in subscription and advertising revenue, despite a decline in hardware sales.
OQB
The Dixie Group, Inc. reported a net income of $1.15 million for the first quarter of 2026, a significant improvement from a loss in the prior year, despite ongoing macroeconomic pressures.
NASDAQ
Septerna, Inc. reported its first-quarter 2026 financial results, highlighting progress in its clinical-stage drug development programs and a significant increase in revenue driven by its collaboration with Novo Nordisk.
NASDAQ
ArriVent BioPharma reports a reduced net loss for Q1 2026 compared to the prior year, with significant cash reserves bolstering its clinical-stage operations and drug development pipeline.
NASDAQ
Ramaco Resources reported a wider net loss for Q1 2026, driven by softer metallurgical coal markets and increased SG&A expenses related to rare earth mineral project development.
NASDAQ
Gain Therapeutics reports increased operating expenses in Q1 2026, with a net loss of $5.6 million, and highlights substantial doubt about its ability to continue as a going concern.
NASDAQ
Columbia Financial, Inc. announced its first quarter 2026 results, showing a significant increase in net income driven by higher net interest income and a lower provision for credit losses.
NASDAQ
Rigetti Computing reports a significant 199% year-over-year revenue increase for Q1 2026, driven by strong sales of quantum computing systems, while managing increased R&D investments.
NYSE
Simon Property Group reports increased Q1 2026 earnings driven by acquisitions and improved lease income, with a 5.2% rise in average base minimum rent.
OQB
Fortitude Gold Corporation reported a net loss of $1.6 million for the first quarter of 2026, with sales declining significantly due to lower production volumes.
NASDAQ
Quantum Computing Inc. reported a significant revenue increase in Q1 2026 driven by recent acquisitions, though the company continues to incur operating losses.
NYSE
Sally Beauty Holdings, Inc. announced its financial results for the second quarter of fiscal year 2026, reporting a 2.3% increase in consolidated net sales to $903.4 million.
NASDAQ
Gladstone Land Corporation's Q1 2026 filing reveals a net loss, driven by a decrease in fixed lease payments and increased operating expenses, alongside strategic debt management and equity issuances.
NASDAQ
Lincoln Educational Services Corporation announced a significant revenue increase of 22.5% in Q1 2026, driven by a substantial rise in student enrollment and strategic program expansion.
NASDAQ
VirTra, Inc. reported a significant 51% decrease in net sales for the first quarter of 2026, primarily due to delayed customer acceptance of deliveries and government funding uncertainties.
NASDAQ
Hudson Technologies Inc. reported a net income of $0.3 million for the first quarter of 2026, a decrease from $2.8 million in the prior year period, impacted by higher SG&A costs and lower gross margin.
NYSE
Owlet, Inc. reported a 6.4% increase in total revenue for Q1 2026, driven by strong subscription growth, though the company still posted a net loss.
NASDAQ
Acurx Pharmaceuticals reports Q1 2026 results, focusing on ibezapolstat development and ongoing financing efforts.
NASDAQ
Phunware, Inc. reported a 21.2% decrease in net revenue for Q1 2026 compared to the prior year, driven by lower software subscription and services revenue, while continuing to invest in AI development.
NYSE
Chart Industries reports a significant decrease in Q1 2026 sales and profits, impacted by lower volumes and unfavorable product mix, while awaiting regulatory approval for its acquisition by Baker Hughes.
NASDAQ
Alico Inc. reported a significant revenue decrease in its Q2 2026 results, largely due to the ongoing wind-down of its citrus operations, while land management and other operations showed growth.
NASDAQ
Bicara Therapeutics Inc. reported a net loss of $56.2 million for the first quarter of 2026, with a significant increase in research and development expenses driven by clinical trial activities.
NASDAQ
Lisata Therapeutics reports Q1 2026 results, detailing progress on its proposed acquisition by Kuva Labs, Inc., and a net loss of $4.49 million.
AMEX
The Arena Group Holdings, Inc. reported a significant revenue decrease in Q1 2026, driven by lower digital advertising and subscription income, alongside strategic adjustments and market softness.
NYSE
Natural Gas Services Group reports a significant increase in Q1 2026 rental revenue, driven by higher horsepower utilization and a strategic focus on large horsepower units.
AMEX
flyExclusive Inc. reported a net loss of $6.5 million for the first quarter of 2026, with revenues increasing by 9.3% year-over-year.